Brokers Issue Forecasts for MDGL FY2028 Earnings
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Equities research analysts at B. Riley issued their FY2028 earnings estimates for Madrigal Pharmaceuticals in a research report issued on Thursday, May 1st. B. Riley analyst M. Mamtani forecasts that the biopharmaceutical company will post earnings of $42.69 per share for the year. B. Riley currently has […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) – Equities research analysts at B. Riley issued their FY2028 earnings estimates for Madrigal Pharmaceuticals in a research report issued on Thursday, May 1st. B. Riley analyst M. Mamtani forecasts that the biopharmaceutical company will post earnings of $42.69 per share for the year. B. Riley currently has […]
